J. Wigren et al., METABOLISM OF 12(S)-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID BY KIDNEYAND LIVER PEROXISOMES, Journal of lipid research, 34(4), 1993, pp. 625-631
12(S)-Hydroperoxy-5,8,10,14-eicosatetraenoic acid (12(S)-HPETE) is one
of the main products formed from arachidonic acid by animal lipoxygen
ases. It is usually reduced to the corresponding hydroxy acid, 12(S)-h
ydroxy-5,8,10,14-eicosatetraenoic acid (12(S)-HETE) or it can serve as
an intermediate in the biosynthesis of hepoxilins. The functions of 1
2(S)-HETE are incompletely understood but it has been proposed that it
plays a role in the metastatic process of certain cancer cells, inclu
ding Lewis lung carcinoma cells. 12(S)-HETE is metabolically degraded
by beta- or omega-oxidation. Indirect evidence has suggested involveme
nt of peroxisomes in the beta-oxidative degradation. The purpose of th
e present investigation was to study 12(S)-HETE metabolism by peroxiso
mes isolated from rat liver or kidney by sucrose density gradient cent
rifugation. The purity of subcellular fractions was determined by mark
er enzyme analyses and electron microscopy. 12(S)-HETE was quantitativ
ely converted by liver or kidney peroxisomes into a single, diethyl et
her-extractable metabolite. This was identified by gas-liquid chromato
graphy-mass spectrometry as 8-hydroxyhexadecatrienoic acid. Lewis lung
carcinoma cells also metabolized 12(S)-HETE to 8-hydroxyhexadecatrien
oic acid.